SLGL Sol-Gel Technologies Ltd Future Profit

SLGL (Sol-Gel) - company brandmark

Sol-Gel Technologies (SLGL) aims for dominance in dermatology through unique microencapsulation of active substances. The projected profit trend illustrates a dependence on external CRO/CMO contractors, while the 0.00 level captures the current state of this process. Stable demand from patients with chronic skin pathologies and FDA approval create a resilient therapeutic ecosystem for business growth.

Sol-Gel Technologies (SLGL): Company Profit Forecast from 07/04/2022 to 11/19/2022

SLGL (Sol-Gel Technologies Ltd): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Stock Price Sol-Gel Technologies|SLGL - Analyst Consensus Forecast
- market capitalization data:
Market Valuation Sol-Gel Technologies|SLGL - Value Adjusted for Debt and Cash
- book capitalization information:
Net Assets per Single Share Sol-Gel Technologies|SLGL - Book Valuation of Business|Market Value to Book Value Ratio sol-gel.com|SLGL - Company Total Assets
- company total debt and liquidity indicators:
Total Debt to Capital Sol-Gel Technologies|SLGL - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Sol-Gel|SLGL - Company Aggregate Debt|Debt to Book Capitalization Ratio Sol-Gel Technologies|SLGL - Long-Term Debt Volume|Company Short-Term Debt Sol-Gel Technologies|Quick Liquidity sol-gel.com
- net income and valuation ratios data:
SLGL - Company Net Income|Future Profit Sol-Gel Technologies|SLGL - Market Cap to Net Income Ratio|Forward P/E Multiple Sol-Gel Technologies Ltd.|SLGL - Price to Net Income Growth Ratio|EV/EBITDA Multiple Sol-Gel Technologies|SLGL - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Sol-Gel Technologies|SLGL - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months sol-gel.com|SLGL - Earnings per share increase in current year|Expected earnings per share growth for next year Sol-Gel Technologies
- revenue and sales details:
SLGL - Company Total Sales|Projected Sales Volume Sol-Gel Technologies|SLGL - Price to Sales|Forward P/S Multiple Sol-Gel Technologies
General company analysis:SLGL, Sol-Gel Technologies
Finished products of Sol-Gel

As a portfolio manager, I view this asset through the lens of long-term capitalization. The indicator aggregates discounted future cash flows to determine the business's fair value relative to current quotes. By analyzing future financial performance metrics, an investor assesses the balance between capital reliability and the risk of overpayment. For Sol-Gel Technologies (SLGL), this metric reflects the monetization of its unique drug encapsulation. Premium pricing in dermatology directly increases projected profits.

Competitor analysis

KRYS (Krystal Biotech, Inc.) - Projected Future Earnings|Projected Future Earnings apogeetherapeutics.com|Future Profit ARQT (Arcutis Biotherapeutics, Inc.)|VCEL (Vericel Corp) - Expected Net Income|Expected Profit Oruka Corp ORKA|Company Profit Forecast Sanara MedTech, Inc. (SMTI)|DBVT - Expected Profit|SLSN - Projected Future Earnings|DERM: Projected Future Earnings|FBRX - Company Profit Forecast|Expected Profit Empro|Net Profit Forecast AXIL (Revive Pro Care)|Expected Profit Medicus Pharma Ltd. (MDCX)|Company Profit Forecast verrica.com|Expected Profit Hoth Therapeutics HOTH|Biofrontera, Inc. (BFRI) - Expected Net Profit|VYNE - Expected Profit|SNOA: Expected Profit|QNRX (quoinpharma.com) - Future Profit|Projected Net Profit azitrainc.com AZTR|DRMA (Dermata Therapeutics, Inc.) - Projected Future Earnings|ELAB - Projected Net Profit|Projected Future Earnings RVNC